Genetic Counseling: Genetic Testing, Family History, and Psychosocial Evaluation

By: Karen Norrgard, Ph.D. (Write Science Right) © 2008 Nature Education
Citation: Norrgard, K. (2008) Genetic counseling: Genetic testing, family history, and psychosocial evaluation. Nature Education 1(1)

A woman with a recent diagnosis of breast cancer is worried about her daughters' risk for the disease. What sort of guidance might a genetic counselor provide in this situation and others like it?

 

Sven is a board-certified health care professional whose patient roster this week includes the following clients:

  • Anya and David, a couple whose three-year-old son has just been diagnosed with Duchenne muscular dystrophy (DMD)
  • Carla, a 37-year-old mother who has just been diagnosed with breast cancer
  • Bali, a 25-year-old woman who is pregnant with her first child

What type of health care professional might have such a diverse client list? If you guessed that this list might belong to a genetic counselor, you are correct.

The Role of the Genetic Counselor

In order to become a genetic counselor in the United States, an individual must first have a master's degree from a program accredited by the American Board of Genetic Counseling (ABGC). Graduates of such programs are then eligible to sit for the board-certification exam, which is administered by the ABGC. Beyond these "official" qualifications, effective genetic counselors must also possess certain personal qualities. For example, because of the diverse applications of genetics to health care, a genetic counselor must be able to tailor each interaction with a client to that client's specific needs. Thus, he or she might provide a client with information about a particular diagnosis, related inheritance patterns, and/or the risk of developing a certain disease. For some clients, a counselor will also coordinate testing and evaluations with other specialists. He or she may additionally provide information about various other resources, including support groups.

Furthermore, for all clients, a genetic counselor must provide supportive counseling and help the client make decisions in a way that is nondirective and client-centered. That is, genetic counselors must empower their clients with factual information while encouraging them to evaluate personal psychosocial values so that they can make the decision that is best for their individual situation (Figure 1).

The Genetic Counselor in Action: Three Case Studies

Remember Sven? As you will see, Sven's clients each have very personal medical, familial, ethical, and psychosocial issues that arise from their unique situations. To effectively meet the needs of these different clients, Sven will have to pull from the four domains of genetic counseling, which are as follows:

  • Communication: Sven will have to communicate with his clients to collect all the pertinent family, medical, and social information.
  • Interpersonal, counseling, and psychosocial assessment skills: Sven must establish rapport with his clients and identify their major concerns; elicit and interpret his clients' experiences, emotions, and perceptions in order to clarify their beliefs and values; and promote client decision making that is unbiased and nondirective.
  • Critical thinking: Sven will need to engage in critical thinking in order to assess and calculate genetic risks; prepare medical and genetic information to help explain sometimes complicated topics; evaluate how personal psychosocial values might impact each client's decision-making process; and provide resources for additional information.
  • Ethics: Of course, Sven is required to act in accordance with the code of ethics of his profession, advocate for his clients, provide information about all of his clients' options, recognize his own limitations, and seek consultation or referral as needed.

Consultation 1: Anya and David

When Sven meets with Anya and David to talk about their three-year-old boy's diagnosis of DMD, he learns that they also have a 10-year-old son and a seven-year-old daughter, and that they hope to have another child in the near future. Sven explains to the couple that DMD is caused by a mutation in the dystrophin gene, which is located on the X chromosome. He reminds them that there is nothing either of them did to cause their son to inherit this disorder. He then explains X-linked recessive disorders, and why, except in rare cases, such disorders only manifest in boys.

Next, Sven tells Anya and David about the patterns of inheritance associated with DMD. He notes that females, who have two X chromosomes, are said to be carriers when they have one X chromosome with the normal gene and one X chromosome with the mutant gene. Because of the presence of the normal copy, female carriers typically do not develop the disease. On the other hand, because males have only one X chromosome and they inherit this chromosome from their mother, any male children of a female carrier of a DMD mutation have a 50% chance of being affected with DMD. Sven makes sure the couple understands that if Anya is a carrier of a DMD mutation, for any future pregnancies, her risk for having a child with DMD is 25%, or 1 in 4 overall. Sven also points out that if Anya is a carrier, then their daughter may also carry the faulty dystrophin gene on one of her two X chromosomes, and may pass it along to her future children.

Sven helps Anya and David sort through many questions related to their situation: What is the prognosis for their son? Will they need help caring for the boy? What treatment and support resources are available for DMD families? Should they have their daughter's carrier status determined now, or let her decide whether to be tested when she is an adult? Do they want Anya to undergo genetic carrier testing so they can better predict their risk of having another affected son? (Note that approximately one-third of women who have a son with DMD but no family history of the disease are not carriers of a DMD mutation. Their sons are therefore considered to have a de novo or "new" mutation, and the woman's chance of having another affected child is no greater than that of the general population.) If Anya is found to be a carrier and the couple decides to have more children, would they consider using in vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD) to select an unaffected embryo for implantation? Might they instead use some other form of medical technology to increase their chances for having a girl? Would they test an ongoing pregnancy for the dystrophin mutation? These questions are ultimately theirs to answer, but Sven must provide any information necessary to help Anya and David reach a decision in a client-centered, nondirective way.

Consultation 2: Carla

Sven's session with Carla is very different. Carla is a 37-year-old mother of three young daughters who has been diagnosed with breast cancer. She is worried about her daughters and wants to know whether they are at risk for developing the same disease. Sven knows that genetic counseling for cancer risk assessment requires many steps. While the inheritance patterns of mutations that are associated with cancer are straightforward and usually autosomal dominant, the actual risk for the individual to develop cancer, even if the mutations are present, is more complex. This is because development of the disease is almost always due to a combination of genetic and environmental factors, many of which are not yet known.

To determine whether Carla's daughters are at an increased risk for breast cancer, Sven must first gather personal medical and family history data to look for evidence of an inherited risk for cancer. Using that information, Sven must then assess the likelihood that Carla has a mutation in one of the breast cancer susceptibility genes, BRCA1 and BRCA2, making sure that she understands that this risk assessment is based on her family history, the age at which she was diagnosed with cancer, her ethnic background, and various other factors.

If Sven determines that Carla's situation meets the criteria to be offered testing, he will obtain her informed consent to be evaluated for mutations in BRCA1 and BRCA2. Sven must feel confident that Carla fully understands the risks, benefits, and limitations of the knowledge that the testing may bring, including matters related to insurability and discrimination. Because of the potentially powerful information obtained from such genetic testing, Sven and Carla must also "contract" about how the results of the testing will be disclosed and to whom. Should Carla share this information with her daughters to prepare them for what might develop, and so they know more about their own cancer risk? What other family members might also be at risk for having the mutation? How will Carla communicate this information to them accurately without alarming them? Carla will also need to make lifestyle and medical decisions about her own health, such as considering prophylactic mastectomy to reduce her risk for developing another tumor in her breast. Finally, Sven must be sure Carla knows about prevention strategies and is aware of environmental factors and lifestyle choices that may increase her or her daughters' cancer risk.

Consultation 3: Bali

Bali is 25 and pregnant with her first child. The results of her triple screen test, a blood test that measures certain fetal protein levels, shows an elevated risk for having a baby with Down syndrome. Because of this elevated risk, Bali's doctor wants her to undergo amniocentesis, which will allow a definitive diagnosis of Down syndrome. The cut-off for calling a woman's risk "elevated" and offering amniocentesis is anything at or above the risk of fetal loss due to the amniocentesis procedure (generally 1 in 200). This is also the age-related risk that any 35-year-old woman has of having a baby with Down syndrome. Therefore, in many places, woman over the age of 35 are routinely offered amniocentesis for every pregnancy.

Bali tells Sven that she knows that babies with Down syndrome are usually born to older mothers, and she therefore believes amniocentesis is unnecessary. During their session, Sven tells Bali her age-related risk for having a baby with Down syndrome, which is approximately 1 in 1,300. Sven then tells Bali about the limitations of the triple screen test and how her increased risk was calculated. Next, they talk about the risks of the amniocentesis procedure. Sven describes the chromosomal basis of Down syndrome and what Bali might expect in caring for a special needs child, putting all of this in the context that her estimated risk is still low.

Finally, Sven tries to assess Bali's personal emotions about, perceptions of, and experiences with Down syndrome, to help her decide whether further testing is right for her. The availability of testing during pregnancy is discussed without persuasion, and the choices Bali has for this pregnancy based on the information from the amniocentesis are discussed.

Finding a Genetic Counselor

With these three examples, you have seen that Sven is an important member of his clients' health care team. Through counseling, Sven helps people understand and adapt to the medical, psychological, and familial implications of genetic contributions to disease. Should you have concerns regarding genetics and disease, you can find a genetic counselor almost anywhere in the United States by clicking on the "Find a counselor" link on the National Society of Genetic Counselors website.

References and Recommended Reading


Forrest, L. E., et. al., 2008, Health first, genetics second: exploring families' experiences of communicating genetic information. European Journal of Human Genetics advance online publication 21 May 2008, doi:10.1038/ejhg.2008.104

National Society of Genetic Counselors, (accessed September 29, 2008).


Flag Inappropriate

This content is currently under construction.

This reading is linked to the following Scitable pages:

For disorders that are preventable or treatable, most people agree that genetic testing makes sense. But for diseases with no preventative measures, would you want to know if you were affected?
Genomics could enable the misuse and abuse of our most personal information. On the other hand, could genetic privacy acts like GINA and HIPAA close the shutters on progress in health research?
The eugenics movement of the early 1900s ultimately went horribly wrong despite its noble aims. What can we learn from this movement’s outcomes in order to avoid the repetition of these mistakes?
All Articles Within Genetics and Society (38)

Genetic Diagnosis and Disease Risks (5)

Genetic Testing and Human Impact (8)

Ethical Considerations (9)

  • Medical Ethics: Genetic Testing and Spinal Muscular Atrophy
    The mutation that causes Spinal Muscular Atrophy (SMA) can be detected in a prenatal screen. But a parent's decision to test for this terrible disease is not as easy as you would think.
  • Genetic Inequality: Human Genetic Engineering
    As genetics allows us to turn the tide on human disease, it's also granting the power to engineer desirable traits into humans. What limits should we create as this technology develops?
  • Human Testing, the Eugenics Movement, and IRBs
    The eugenics movement of the early 1900s ultimately went horribly wrong despite its noble aims. What can we learn from this movement’s outcomes in order to avoid the repetition of these mistakes?
  • Bioethics in Genetics
    Can bioethics ever represent too much of a good thing? Where exactly is the line between too little and too much protection for patients in genetic counseling, research, and testing?
  • Diagnostic Testing and the Ethics of Patenting DNA
    Intellectual property rights offset the financial risks of funding research but limit information access. Can a balance between private interests and public desire for treatments be achieved?
  • Embryo Screening and the Ethics of Human Genetic Engineering
    What if you could screen embryos for diseases before they became babies? What if you had the power to choose the traits your baby would have? Would you use it?
  • Protecting Your Genetic Identity: GINA and HIPAA
    Genomics could enable the misuse and abuse of our most personal information. On the other hand, could genetic privacy acts like GINA and HIPAA close the shutters on progress in health research?
  • Questionable Prognostic Value of Genetic Testing
    Many experts predict that genetic testing for disease susceptibility is well on its way to becoming a routine part of clinical care. Yet many of the genetic tests currently being developed are, in the words of the World Health Organization (WHO), of “questionable prognostic value.” How can this be?
  • Ethics of Genetic Testing: Medical Insurance and Genetic Discrimination
    For disorders that are preventable or treatable, most people agree that genetic testing makes sense. But for diseases with no preventative measures, would you want to know if you were affected?

Genetically-Tailored Treatment (6)

Social Uses of Genetic Discovery (7)

Genetics and the Law (5)

  • Diagnostic Testing and the Ethics of Patenting DNA
    Intellectual property rights offset the financial risks of funding research but limit information access. Can a balance between private interests and public desire for treatments be achieved?
  • Protecting Your Genetic Identity: GINA and HIPAA
    Genomics could enable the misuse and abuse of our most personal information. On the other hand, could genetic privacy acts like GINA and HIPAA close the shutters on progress in health research?
  • Forensics, DNA Fingerprinting, and CODIS
    How ethical is it to keep a database of convicted felons' DNA profiles? Can we rely on DNA fingerprints for conviction? Many ethical issues surround the use of DNA in forensic technology.
  • Legislative Landmarks of Forensics: California v. Greenwood and Shed DNA
    Everywhere we go, we leave our DNA behind. Forensics profits from this “abandoned” DNA to solve crimes. As technology improves, could we wind up with a database of everyone’s DNA – including yours?
  • Sports, Gene Doping, and WADA
    Gene doping could stretch the physical limits of human strength and endurance. What are the consequences of gene therapy in sports competition, and more, importantly, is it safe?
 
Ask an Expert
Post Question



Nature Education Home Learn More About Faculty Page Students Page Feedback



Genetics

Event Reminder